Please use this identifier to cite or link to this item:
http://ir.mu.ac.ke:8080/jspui/handle/123456789/6955
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ciaranello, Andrea L. | - |
dc.contributor.author | Morris, Bethany L. | - |
dc.contributor.author | Walensky, Rochelle P. | - |
dc.contributor.author | Weinstein, Milton C. | - |
dc.contributor.author | Ayaya, Samuel | - |
dc.contributor.author | Doherty, Kathleen | - |
dc.contributor.author | Leroy, Valeriane | - |
dc.contributor.author | Hou, Taige | - |
dc.contributor.author | Desmonde, Sophie | - |
dc.contributor.author | Lu, Zhigang | - |
dc.contributor.author | Noubary, Farzad | - |
dc.contributor.author | Patel, Kunjal | - |
dc.contributor.author | Ramirez-Avila, Lynn | - |
dc.contributor.author | Losina, Elena | - |
dc.contributor.author | Seage, George R. | - |
dc.contributor.author | Freedberg, Kenneth A | - |
dc.date.accessioned | 2022-10-25T07:39:54Z | - |
dc.date.available | 2022-10-25T07:39:54Z | - |
dc.date.issued | 2013-12-13 | - |
dc.identifier.uri | http://ir.mu.ac.ke:8080/jspui/handle/123456789/6955 | - |
dc.description.abstract | Background: Computer simulation models can project long-term patient outcomes and inform health policy. We internally validated and then calibrated a model of HIV disease in children before initiation of antiretroviral therapy to provide a framework against which to compare the impact of pediatric HIV treatment strategies. Methods: We developed a patient-level (Monte Carlo) model of HIV progression among untreated children <5 years of age, using the Cost-Effectiveness of Preventing AIDS Complications model framework: the CEPAC-Pediatric model. We populated the model with data on opportunistic infection and mortality risks from the International Epidemiologic Database to Evaluate AIDS (IeDEA), with mean CD4% at birth (42%) and mean CD4% decline (1.4%/ month) from the Women and Infants’ Transmission Study (WITS). We internally validated the model by varying WITS-derived CD4% data, comparing the corresponding model-generated survival curves to empirical survival curves from IeDEA, and identifying best-fitting parameter sets as those with a root-mean square error (RMSE) <0.01. We then calibrated the model to other African settings by systematically varying immunologic and HIV mortality- related input parameters. Model-generated survival curves for children aged 0-60 months were compared, again using RMSE, to UNAIDS data from >1,300 untreated, HIV-infected African children. Results: In internal validation analyses, model-generated survival curves fit IeDEA data well; modeled and observed survival at 16 months of age were 91.2% and 91.1%, respectively. RMSE varied widely with variations in CD4% parameters; the best fitting parameter set (RMSE = 0.00423) resulted when CD4% was 45% at birth and declined by 6%/month (ages 0-3 months) and 0.3%/month (ages >3 months). In calibration analyses, increases in IeDEA-derived mortality risks were necessary to fit UNAIDS survival data. Conclusions: The CEPAC-Pediatric model performed well in internal validation analyses. Increases in modeled mortality risks required to match UNAIDS data highlight the importance of pre-enrollment mortality in many pediatric cohort studies. | en_US |
dc.language.iso | en | en_US |
dc.publisher | PLOS ONE | en_US |
dc.subject | Computer simulation | en_US |
dc.subject | Health policy | en_US |
dc.subject | HIV disease | en_US |
dc.subject | Pediatric | en_US |
dc.subject | Antiretroviral therapy | en_US |
dc.title | Validation and calibration of a computer simulation model of pediatric HIV infection | en_US |
dc.type | Article | en_US |
Appears in Collections: | School of Medicine |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.